Clinical Trial: A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid

U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623915) titled 'A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid' on May 29.

Brief Summary: This trial is a multicenter randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.

Study Start Date: June 12

Study Type: INTERVENTIONAL

Condition: Primary Hyperlipidemia

Intervention: DRUG: Bempedoic Acid Tablet

bempedoic acid 180 mg tablet taken orally, once daily. Participants in the experiment remain on ongoing lipid-modifying therapy

DRUG: Placebo

Matching placebo tablet taken orally, once...